242 filings
Page 7 of 13
8-K
1zuautk l7
10 May 18
Diffusion Pharmaceuticals Reports First Quarter 2018 Financial Results and Provides Business Update
4:37pm
8-K
h7lk3c11d
3 Apr 18
Diffusion Pharmaceuticals Reports 2017 Financial Results and Provides Business Update
12:00am
8-K
cz3gi3mti
19 Mar 18
Departure of Directors or Certain Officers
12:00am
8-K
gsvxv ncacn66
5 Mar 18
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
12:00am
8-K
mzwsocippdr 2af
22 Jan 18
Other Events
12:00am
8-K
cq0ucpm8v6b55pvk ay
19 Jan 18
Diffusion Pharmaceuticals Announces $12 Million Underwritten Public Offering
12:00am
8-K
54u0mb9pk5qey
29 Dec 17
Diffusion Pharmaceuticals Begins Phase 3 Clinical Trial with TSC in Glioblastoma Multiforme
12:00am
8-K
l19q 15x62
20 Nov 17
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
12:00am
8-K
bccuqmap
13 Nov 17
Diffusion Pharmaceuticals Reports Third Quarter 2017 Financial Results and Provides Business Update
12:00am
8-K
5wqo hl7jmmn7ubh
2 Nov 17
Amendments to Articles of Incorporation or Bylaws
12:00am
8-K
z0bhey wg
14 Aug 17
Diffusion Pharmaceuticals Reports Second Quarter 2017 Financial Results and Provides Business Update
12:00am
8-K
n6z8oxom
6 Jul 17
Departure of Directors or Certain Officers
12:00am
8-K
alu8cm62
16 Jun 17
Submission of Matters to a Vote of Security Holders
12:00am
8-K
j40df0t9efkrtr3nw
26 May 17
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
12:00am
8-K
76kjsahk czx
22 May 17
Regulation FD Disclosure
12:00am
8-K
xuu rueqp8
15 May 17
Diffusion Pharmaceuticals Provides Corporate Highlights and Reports Financial First Quarter 2017 Results
12:00am
8-K
66x8to0xnrp33q6r4c
15 May 17
Diffusion Pharmaceuticals Provides Corporate Highlights and Reports Financial First Quarter 2017 Results
12:00am
8-K
3qumgluj1d
11 Apr 17
Shareholder Nominations Pursuant to Exchange Act Rule 14a-11
12:00am
8-K
2of8za qc9w50kp
3 Apr 17
Diffusion Pharmaceuticals Announces Closing of Oversubscribed Private Placement
12:00am
8-K
itqhlo8smjp 8k59s
31 Mar 17
Diffusion Pharmaceuticals Provides Corporate Highlights and Reports
12:00am